Biomarkers for visceral hypersensitivity in patients with irritable bowel syndrome.

Zlatan MujagicD M A E JonkersS LudidiD KeszthelyiM A HesselinkZ Z R M WeertsR N KievitJ F AlthofC LeueJ W KruimelF J van SchootenA A M Masclee

Published in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2017)

Our findings do not support a role for the biological processes as ascertained by biomarkers in visceral hypersensitivity in IBS patients. This study is registered in the US National Library of Medicine (clinicaltrials.gov, NCT00775060).

Keyphrases

irritable bowel syndrome
end stage renal disease
insulin resistance
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
type diabetes
quality improvement
adipose tissue
skeletal muscle
patient reported